About Investors Technology Products News Contact Committed to Quality We are committed to delivering high quality products with outstanding value built on the foundation of a dynamic goal-oriented quality management system. Our continual investment in quality ensures that we exceed the expectations of our shareholders, customers, partners, key stakeholders, and employees. Our quality management system is ISO 9001:2008 and ISO 13485:2003 certified, compliant with the United States Food and Drug Administration’s current Good Manufacturing Practices (cGMP: Quality System Regulation Part 820 of CFR Title 21, Volume 8), European Union’s Directive 98/79/EC on in vitro diagnostic medical devices, and Health Canada Medical Device Regulations (SOR/98-282). Additionally, we adhere to ISO 14971 (Application of Risk Management to Medical Devices) and ISO 2859 (Sampling Procedures for Inspection by Attributes). Certification and compliance to these requirements attests to our ability to maintain the highest standard of quality in medical device manufacturing, product development and corporate conduct. PROVEN QUALITY Our rapid tests have been evaluated and approved by a broad range of health regulators and agencies including: United States Food & Drug Administration Health Canada China Food and Drug Administration, P.R. China European Union CE Mark United Nations Agencies UN Development Programme (UNDP) UN Population Fund (UNFPA) UN Office for Project Services (UNOPS) UN Office at Vienna (UNOV) International Trade Centre (ITC) United States Agency for International Development Pan American Health Organization CONTACT US | LEGAL INFO | NEWS & EVENTS ©2020 MedMira Inc. All Rights Reserved. Follow us on

About Investors Technology Products News Contact Out of an intense passion for science and a desire to create diagnostics that could impact healthcare on a global level, MedMira was born. In 1993, co-founders Hermes Chan and Carlina Hui, both recent graduates of Acadia University in Wolfville, Nova Scotia, brought their innovation to life. MedMira Rapid Vertical Flow Technology™ – a MEDical MIRAcle – enables rapid tests that instantly detect antibodies to infectious, sexually transmitted, tropical and other diseases, and any other target of interest. Today, MedMira’s technology platform and testing solutions are known worldwide for their quality, accuracy and speed, and our HIV test is the only one in the world to earn the approval of Health Canada, the United States Food & Drug Administration (FDA), the European Union (CE) and the China Food and Drug Administration (CFDA). Through MedMira, Hermes and Carlina have achieved both professional and personal success. MedMira’s patented technology and rapid tests have been recognized on the world stage through top tier regulatory approvals, endorsement by leading global organizations such as the United Nations and United States Army, and various industry awards. Hermes and Carlina take great pride in the advancements they have contributed to global healthcare and the biotechnology industry. LEARN MORE > CONTACT US | LEGAL INFO | NEWS & EVENTS ©2020 MedMira Inc. All Rights Reserved. Follow us on